Hot Beauty products at NACDS Total Store Expo 2014
Kiss of Care & Color
Beiersdorf’s Nivea brand has married the benefits of Nivea moisture with sheer color to create Nivea Kiss of Care & Color. The exclusive Nivea Moisture Core Technology, which is formulated with shea butter, is wrapped in a shell of color for smooth, soft lips. It has a suggested retail price of $4.99 and comes in five shades to take beauty mavens from day to night: sheer coral, sheer pink, sheer crimson, sheer berry and sheer caramel.
ColourB4 Extra Strength
The United Kingdom’s ColourB4 has come stateside to rescue at-home hair coloring disasters. With a single application, ColourB4 promises to make salon-style hair dye removal available to everyone. It can tackle both permanent and semi-permanent hair color, and also can remove color buildup and darkened tones. After using ColourB4, your hair is ready for re-coloring. The brand recently announced English celebrity and former model Katie Price as its first global ambassador.
Toddler Training Toothpaste
Looking to help keep a baby’s first smile healthy and help instill good brushing habits early on, Tom’s of Maine has created the new natural Toddler Training Toothpaste. The toothpaste cleans tiny teeth and gums with ingredients derived solely from plants and minerals. The maker of natural personal care products said the toothpaste is safe if swallowed and fluoride-free. It also is free of gluten, propylene glycol and sodium lauryl sulfate. With a suggested retail price of $3.99, the new Toddler Training Toothpaste rounds out the company’s children’s natural oral care portfolio.
Triple Defense Sunscreen for Men
With research revealing a need among men for greater use of sunscreen, Banana Boat has developed the first Banana Boat sunscreen specifically for guys. According to a 2012 survey by the Skin Cancer Foundation, men older than 50 years are more than twice as likely as women to develop skin cancer, yet only 51% of men in the United States admitted to using sunscreen in the past 12 months. Men also were found to be less knowledgeable than women about the proper methods to protect themselves against sun exposure and skin cancer. Ideal for active males, Banana Boat Triple Defense Sunscreen for Men contains ActiveProtect Technology and provides heavy-duty broad spectrum UVA/UVB protection, which kicks in and stays strong when the sun’s rays are most intense.
B’iota Botanicals, a European brand in herbal hair and skin care solutions, has hit the U.S. market to help men and women battling weak, damaged and thinning hair. The core products for the U.S. launch are B’iota shampoos and leave-in serum, which have been clinically tested and shown to reduce hair fallout and thinning by promoting stronger, thicker, fuller hair, the company stated. B’iota Botanical Laboratories was founded in 2002 and is headquartered in Istanbul. With a recent $50 million expansion, it is now the third-largest pharmaceutical-grade cosmetics manufacturing facility in Europe.
FDA approves Genzyme’s Cerdelga
SILVER SPRING, Md. — The Food and Drug Administration has approved Cerdelga (eliglustat) for the treatment of adult patients with the Type 1 form of Gaucher disease
The disorder — which affects about 6,000 people in the United States, according to the agency — occurs in people who don't produce enough glucocerebrosidase enzyme. This deficiency causes fatty materials to collect in the spleen, liver and bone marrow. Major symptoms of the disease include liver and spleen enlargement, anemia, low blood platelet counts and bone problems. Cerdelga works by slowing down the development of fatty materials by inhibiting the metabolic activity that forms them.
“Today’s approval offers another important treatment option for patients with Type 1 Gaucher disease,” said Amy G. Egan, M.D., M.P.H., deputy director of the Office of Drug Evaluation III in FDA’s Center for Drug Evaluation and Research. “In addition, Cerdelga received orphan drug designation from the FDA, reflecting the agency’s focus and commitment to the development of treatments for rare diseases.”
Cerdelga is manufactured by Genzyme.
Appreciating pharmacy’s advancement
One of the greatest frustrations that one can encounter is the sense of not being heard or understood. So, understandably, pharmacy was extremely frustrated in past years.
For a long time, pharmacy was performing a vital role in patient care, but without a corresponding level of appreciation from the government and from the healthcare community.
When I started as president and CEO of the National Association of Chain Drug Stores in 2007, I often heard from NACDS members and allies that the profession and the industry had to stop “talking to itself” and “preaching to the choir,” and had to be more proactive in communicating pharmacy’s value externally.
Studies validated that point. In 2007, NACDS conducted opinion research among policy-makers, opinion leaders and other influential audiences. It showed that respondents really liked their pharmacies, but had not thought much about pharmacies as part of healthcare delivery. Unfortunately, the treatment — or mistreatment — of pharmacy in public policy reflected that sentiment.
A lot has happened since then. Some of it has flowed from external forces, and much of it has flowed from pharmacy’s proactive stance. Here are just a few examples:
- Any discussion of pharmacy advancement starts with pharmacies themselves. NACDS members have transformed their stores into healthcare destinations and expanded the services they offer;
- Pharmacies proved their accessibility, capacity and capability — particularly in the minds of public health officials — when they emerged as strategic vaccination partners in the face of influenza outbreaks, including H1N1;
- The healthcare reform debate created a venue for pharmacy to make its pitch for the value that it provides. In addition, it became clear that the rollout of the Affordable Care Act required assistance from pharmacies, who are considered by patients to be "go-to” information sources;
- NACDS launched and sustained its communications and advocacy theme: “Pharmacies. The face of neighborhood healthcare”;
- The pipeline of research has yielded proof of what pharmacy has been saying for years. Research regarding benefits of medication adherence — and pharmacy’s ability to foster it — is appearing consistently in peer-reviewed journals, and in policy statements of the Centers for Medicare and Medicaid Services and the Congressional Budget Office;
- The mainstream media have increased their reporting of new pharmacy services, particularly in the face of mounting healthcare access challenges; and
- Pharmacies have become more engaged in grassroots advocacy. NACDS members hosted 118 pharmacy tours and other events for members of Congress in 2013, and have already hosted 103 events in 2014.
We’ve come a long way. Legislation was introduced this year in the U.S. House of Representatives to designate pharmacists as healthcare providers under Medicare Part B, to assist underserved communities. The legislation would enable pharmacists to provide vaccinations, diabetes screenings and self-management education, cardiovascular screenings and more to Medicare patients — as allowed by state laws. An online survey in July of likely voters who are informed and engaged when it comes to current events found that 79% of respondents favor the legislation. The survey, conducted by Public Opinion Strategies and commissioned by NACDS, also found bipartisan support with 85% of Democrats and 76% of Republicans backing it. This reflects the bill’s current co-sponsorship, with 50 Democrats and 44 Republicans cosponsoring it in the House.
Looking back over how far we have come, one could argue that it is time for pharmacy to focus on internal communications again. However, instead of “preaching to the choir,” the message would be one of thanks — for the industry’s great work that has elevated pharmacy’s status and appreciation.
Much work lies ahead to achieve pharmacy’s potential. However, doing that work will be much more rewarding than enduring past frustrations. It also will be much more productive for the patients whom this amazing industry serves.
Steve Anderson, IOM, CAE, is president and CEO of the National Association of Chain Drug Stores.